Clinical Trials on Thyroid-associated Ophthalmopathy

Total 4014 results

Horizon Pharma USA, Inc.

Completed

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

Thyroid-Associated Ophthalmopathy | Thyroid Associated Ophthalmopathies

United Kingdom, United States, Germany, Italy
Dalian University

Completed

99Tc-MDP for Thyroid-Associated Ophthalmopathy

Thyroid-Associated Ophthalmopathy

China
Yonsei University

Completed

Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections

Thyroid-associated Ophthalmopathy

Korea, Republic of
Ipsen

Terminated

Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment

Thyroid-Associated Ophthalmopathy

Spain
Sun Yat-sen University

Recruiting

Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy

Immune System Diseases | Autoimmune Diseases | Endocrine System Diseases | Thyroid Diseases | Eye Diseases, Hereditary | Graves Ophthalmopathy | Graves Disease | Hyperthyroidism | Thyroid-associated Ophthalmopathy

China
Rebecca Bahn
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Trial of Rituximab for Graves' Ophthalmopathy

Thyroid-associated Ophthalmopathy

United States
Columbia University
International Thyroid Eye Disease Society

Withdrawn

Selenium in Mild Thyroid Eye Disease in North America (S-ITEDS)

Thyroid Associated Ophthalmopathies
Haukeland University Hospital

Completed

New Treatment for Patients With Temporal Hollowing After Lateral Wall Decompression

Thyroid-Associated Ophthalmopathy

Norway
Lund University

Recruiting

Treatment of Graves´Ophthalmopathy With Simvastatin (GO-S)

Graves Ophthalmopathy | Thyroid Associated Ophthalmopathy | Thyroid Associated Orbitopathy

Sweden
Haukeland University Hospital

Recruiting

Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease

Thyroid-Associated Ophthalmopathy

Norway
Medical University of Vienna

Completed

The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy

Dry Eye Syndrome | Thyroid-associated Ophthalmopathy

Austria
Rabin Medical Center

Completed

Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues

Thyroid Associated Ophthalmopathies

Israel
Sun Yat-sen University

Recruiting

Multi-model Image of Immunosuppressive Agents in TAO

Thyroid Associated Ophthalmopathy

China
Peking University People's Hospital

Active, not recruiting

A Study of IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy

Thyroid Associated Ophthalmopathy

China
Sun Yat-sen University

Withdrawn

Efficacy and Safety of Tocilizumab for TAO

Thyroid Associated Ophthalmopathy | Tocilizumab

China
Sun Yat-sen University

Recruiting

Multi-model Image of Doxycycline in TAO

Thyroid Associated Ophthalmopathy

China
Neon Hospital
Ondokuz Mayıs University

Completed

Optic Disc, Macula, and Retinal Nerve Fiber Layer Measurements Obtained by OCT in Thyroid Associated Ophthalmopathy

Thyroid Associated Ophthalmopathy
Hospital Clinico Universitario de Santiago
Fundación Ramón Domínguez

Completed

Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease) (GRC)

Thyroid Eye Disease | Thyroid Associated Ophthalmopathies | Graves´ Ophthalmopathy

Spain
Göteborg University
Sahlgrenska University Hospital, Sweden

Active, not recruiting

Rituximab (RTX) Therapy in Patients With Active TAO

Ophthalmopathy, Thyroid-Associated

Sweden
Jie Shen
Zhujiang Hospital; The Fifth Affiliated Hospital of Southern Medical University and other collaborators

Unknown

Using A Novel Classification System in Intravenous GCs Therapy of TAO: A Multi-central, Randomized, Open, Superior Trial

Thyroid Associated Ophthalmopathy

China
Janjira Petsuksiri
Mahidol University

Not yet recruiting

Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)

Thyroid Associated Ophthalmopathy

Thailand
Sun Yat-sen University

Recruiting

Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO

Thyroid Associated Ophthalmopathy

China
University of Pisa

Not yet recruiting

A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy (ORGO)

Thyroid Associated Ophthalmopathy
Sun Yat-sen University

Unknown

Natural History and Risk Factors of TAO

Thyroid Associated Ophthalmopathy

China
Odense University Hospital

Completed

Rituximab in the Treatment of Graves' Disease

Thyroid Associated Ophthalmopathy | Graves´ Disease

Denmark
Althaia Xarxa Assistencial Universitària de Manresa
Societat Catalana d'Oftalmologia

Recruiting

Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.

Surgical Procedure, Unspecified | Thyroid Associated Ophthalmopathy

Spain
Sun Yat-sen University

Not yet recruiting

Combination of Orbital Compression Surgery and Strabismus Surgery for Thyroid Associated Ophthalmopathy

Thyroid Associated Ophthalmopathy

China
Lassen Therapeutics Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

Eye Diseases | Endocrine System Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis

United States, United Kingdom, Spain
Sling Therapeutics, Inc.

Recruiting

A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Eye Diseases | Endocrine System Diseases | Thyroid Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Exophthalmos | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis | IGF1R | Hashimoto

United States
Sling Therapeutics, Inc.

Recruiting

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (LIDS)

Eye Diseases | Endocrine System Diseases | Thyroid Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Exophthalmos | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis | IGF1R | Hashimoto

United States, Spain, Canada, Italy, United Kingdom
University of Pisa

Completed

Effects of Atorvastatin in Graves' Orbitopathy (GO) (STAGO)

Hypercholesterolemia | Thyroid Associated Ophthalmopathy

Italy
Cairo University

Completed

Thyroid Associated Orbitopathy Treatment by Methotrexate Against Triamcinolone Periocular Injections (TOMATO)

Thyroid Associated Orbitopathy

Egypt
Silkiss, Rona Z., M.D., FACS
Lauer, Simeon, M.D.; Reier, Alice M.D.; Coleman, Morton M.D.

Completed

Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy

Thyroid Related Orbitopathy | Graves' Dysthyroid Ophthalmopathy

United States
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Thyroid Ophthalmopathy

China
Sun Yat-sen University

Unknown

Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy

Thyroid Associated Opthalmopathies

China
Medical University of Warsaw

Recruiting

Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)

Thyroid Eye Disease | Ophthalmopathy | Orbitopathy, Graves

Poland
Ankara University

Unknown

The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy

Graves' Ophthalmopathy

Turkey
All India Institute of Medical Sciences, Bhubaneswar

Not yet recruiting

Study on Efficacy of Add on Selenium in Mild-to-moderate Graves Ophthalmopathy

Thyroid Eye Disease | Graves Ophthalmopathy

India
Yonsei University

Unknown

The Effects of Metformin in Patients With Mild Graves' Ophthalmopathy

Mild Graves' Ophthalmopathy

Korea, Republic of
Sun Yat-sen University

Unknown

Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal People

Graves' Ophthalmopathy

China
Ruijin Hospital

Unknown

A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy

Graves' Ophthalmopathy

China
National Taiwan University Hospital

Unknown

The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves'Ophthalmopathy

Graves' Ophthalmopathy

Taiwan
Medical University of Vienna

Unknown

Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy

Graves Ophthalmopathy | Graves Disease | Graves' Ophthalmopathy Worsened

Austria
University of Sao Paulo

Completed

Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy

Graves' Ophthalmopathy | Graves' Disease

Brazil
Immunovant Sciences GmbH

Terminated

ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )

Graves' Ophthalmopathy (GO)

United States, Germany, Spain, Canada, Italy
Immunovant Sciences GmbH

Completed

Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)

Graves' Ophthalmopathy

Canada
Barwon Health
National Health and Medical Research Council, Australia; University of Melbourne

Completed

Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies

Graves' Ophthalmopathy

Australia
Fondation Ophtalmologique Adolphe de Rothschild

Completed

mDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX) (DDX)

Dysthyroid Ophthalmopathies

France
Allergan

Completed

A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants

Hypothyroidism | Thyroid Disease | Euthyroid | Thyroid Gland | Thyroid Hormones

United States
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Azienda Ospedaliero, Universitaria Pisana; Istituto Auxologico Italiano; Azienda... and other collaborators

Recruiting

Tocilizumab in Active Moderate-severe Graves' Orbitopathy (TOGO)

Graves Ophthalmopathy

Italy

Clinical Trials on Thyroid-associated Ophthalmopathy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations